Search

Your search keyword '"Paul, Friedemann"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Paul, Friedemann" Remove constraint Author: "Paul, Friedemann" Topic 110904 neurology and neuromuscular diseases Remove constraint Topic: 110904 neurology and neuromuscular diseases
66 results on '"Paul, Friedemann"'

Search Results

1. sj-docx-1-msj-10.1177_13524585231172145 – Supplemental material for Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

2. sj-docx-1-msj-10.1177_13524585231151212 – Supplemental material for Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)

3. sj-docx-1-msj-10.1177_13524585231151212 – Supplemental material for Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)

4. sj-docx-11-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

5. sj-pdf-2-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

6. sj-pdf-6-mso-10.1177_20552173221109770 - Supplemental material for Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity

7. sj-docx-1-msj-10.1177_13524585221118677 – Supplemental material for Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis

8. sj-docx-4-mso-10.1177_20552173221109770 - Supplemental material for Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity

9. sj-docx-13-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

10. sj-docx-5-mso-10.1177_20552173221109770 - Supplemental material for Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity

11. sj-docx-12-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

12. sj-docx-17-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

13. sj-docx-18-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

14. sj-docx-19-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

15. sj-docx-1-msj-10.1177_13524585221118677 – Supplemental material for Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis

16. sj-docx-16-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

17. sj-docx-9-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

18. sj-docx-12-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

19. sj-docx-17-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

20. sj-pdf-3-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

21. sj-docx-8-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

22. sj-docx-14-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

23. sj-docx-8-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

24. sj-docx-15-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

25. sj-docx-18-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

26. sj-docx-19-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

27. sj-docx-11-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

28. sj-pdf-1-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

29. sj-docx-9-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

30. sj-docx-4-mso-10.1177_20552173221109770 - Supplemental material for Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity

31. sj-pdf-2-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

32. sj-pdf-1-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

33. sj-docx-15-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

34. sj-docx-1-mso-10.1177_20552173221109770 - Supplemental material for Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity

35. sj-pdf-4-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

36. sj-docx-16-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

37. sj-docx-10-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

38. sj-docx-1-mso-10.1177_20552173221109770 - Supplemental material for Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity

39. sj-pdf-3-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

40. sj-pdf-2-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

41. sj-pdf-1-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

42. sj-docx-2-msj-10.1177_13524585211039753 – Supplemental material for Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry

43. sj-pdf-1-msj-10.1177_1352458521988926 – Supplemental material for Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD

44. sj-pdf-2-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

45. sj-pdf-1-mso-10.1177_20552173211032334 - Supplemental material for Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina

46. sj-pdf-1-msj-10.1177_1352458521988926 – Supplemental material for Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD

47. sj-pdf-4-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

48. sj-pdf-3-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation

49. sj-pdf-1-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation

50. sj-pdf-4-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

Catalog

Books, media, physical & digital resources